Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) Share Price

Company Profile

Business description
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company’s comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client’s projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Contact
No. 2, Lane 720, Cailun Road
Room 501, Pilot Free Trade Zone
Shanghai201203
CHN
T: +86 2158338205
http://www.chemexpress.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
4,195

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,966.10	59.30	-0.66%
CAC 40	8,227.32	70.89	0.87%
DAX 40	24,155.45	39.45	-0.16%
Dow JONES (US)	49,310.32	179.71	-0.36%
FTSE 100	10,457.01	19.45	-0.19%
HKSE	25,678.44	236.76	-0.91%
NASDAQ	24,438.50	219.06	-0.89%
Nikkei 225	59,446.98	306.75	0.52%
NZX 50 Index	12,850.26	34.67	-0.27%
S&P 500	7,108.40	29.50	-0.41%
S&P/ASX 200	8,740.60	58.00	-0.66%
SSE Composite Index	4,069.44	23.81	-0.58%